[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR3080278B1 - Procede de fabrication d'un spheroide de cannabidiol - Google Patents

Procede de fabrication d'un spheroide de cannabidiol Download PDF

Info

Publication number
FR3080278B1
FR3080278B1 FR1853165A FR1853165A FR3080278B1 FR 3080278 B1 FR3080278 B1 FR 3080278B1 FR 1853165 A FR1853165 A FR 1853165A FR 1853165 A FR1853165 A FR 1853165A FR 3080278 B1 FR3080278 B1 FR 3080278B1
Authority
FR
France
Prior art keywords
cannabidiol
active
manufacturing
active principle
spheroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1853165A
Other languages
English (en)
Other versions
FR3080278A1 (fr
Inventor
Michel Iderne
Olivier Jacob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ghs Patents Ltd
Original Assignee
Ghs Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghs Patents Ltd filed Critical Ghs Patents Ltd
Priority to FR1853165A priority Critical patent/FR3080278B1/fr
Priority to PCT/IB2019/052937 priority patent/WO2019198001A1/fr
Publication of FR3080278A1 publication Critical patent/FR3080278A1/fr
Application granted granted Critical
Publication of FR3080278B1 publication Critical patent/FR3080278B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procédé de fabrication d'un sphéroïde comprenant du cannabidiol dans lequel : a) On mélange un principe actif isolé, une solution active d'origine végétale contenant ledit principe actif ou un précurseur de celui-ci, avec une substance absorbante et adsorbante présentant des propriétés plastiques, b) on extrude ledit mélange jusqu'à obtention d'un produit extrudé, c) on sphéronise ledit produit extrudé jusqu'à obtention d'un sphéroïde, caractérisé en ce que ledit principe actif isolé consiste en du cannabidiol et en ce que ladite solution active d'origine végétale consiste en un extrait actif, issu d'un végétal du genre Cannabis sativa L, contenant du cannabidiol et/ou un précurseur de cannabidiol.
FR1853165A 2018-04-11 2018-04-11 Procede de fabrication d'un spheroide de cannabidiol Active FR3080278B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1853165A FR3080278B1 (fr) 2018-04-11 2018-04-11 Procede de fabrication d'un spheroide de cannabidiol
PCT/IB2019/052937 WO2019198001A1 (fr) 2018-04-11 2019-04-10 Procede de fabrication d'un spheroide comprenant du cannabidiol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1853165 2018-04-11
FR1853165A FR3080278B1 (fr) 2018-04-11 2018-04-11 Procede de fabrication d'un spheroide de cannabidiol

Publications (2)

Publication Number Publication Date
FR3080278A1 FR3080278A1 (fr) 2019-10-25
FR3080278B1 true FR3080278B1 (fr) 2021-04-30

Family

ID=66476677

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1853165A Active FR3080278B1 (fr) 2018-04-11 2018-04-11 Procede de fabrication d'un spheroide de cannabidiol

Country Status (2)

Country Link
FR (1) FR3080278B1 (fr)
WO (1) WO2019198001A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021226725A1 (fr) * 2020-05-15 2021-11-18 Hexo Operations Inc. Haschich présentant des caractéristiques sensiblement uniformes et son procédé de production à une échelle industrielle

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
FR2794346B1 (fr) * 1999-06-02 2004-08-06 Ile D Inventeurs Apis Spheromo Formulation et procede de production de spheroides a partir d'une boisson fermentee ou d'un jus fermente par exemple du vin
RS53624B1 (en) * 2006-03-16 2015-04-30 Euro-Celtique S.A. PHARMACEUTICAL SFEROIDS
WO2008021394A2 (fr) * 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Formulations pharmaceutiques d'agonistes cannabinoïdes et procédé d'utilisation

Also Published As

Publication number Publication date
WO2019198001A1 (fr) 2019-10-17
FR3080278A1 (fr) 2019-10-25

Similar Documents

Publication Publication Date Title
Ma et al. Preventive effect of aspirin eugenol ester on thrombosis in κ-carrageenan-induced rat tail thrombosis model
MA50667A (fr) Molécule multispécifique de liaison à l'antigène ayant une activité de substitution de la fonction de cofacteur du facteur viii de coagulation sanguine (fviii), et formulation pharmaceutique contenant ladite molécule en tant que principe actif
CL2019002247A1 (es) Proceso de granulación de polihalita.
FR3080278B1 (fr) Procede de fabrication d'un spheroide de cannabidiol
BR112017017574A2 (pt) processo para a produção de um produto de ureia estabilizado por formaldeído.
JP2014520526A5 (fr)
FR3065644B1 (fr) Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation
BR112014004632A2 (pt) processo e dispositivo de extrusão
BR112014001536A2 (pt) método para a fabricação de material pulverizado e pulverizador vibrante
FR3048982B1 (fr) Procede de fabrication de papier impregne par un fluide a pression supercritique - papier impregne, notamment colore
FR3069413B1 (fr) Extrait hydrosoluble de propolis, procede d'obtention et utilisation pour prevenir et/ou lutter contre les maladies des vegetaux
FR3052978B1 (fr) Procede d'obtention d'un extrait d'armeria maritima enrichi en diglycosides et son utilisation en cosmetique
BRPI0516343A2 (pt) processo para a formaÇço rÁpida de um aerossol constante e respectivos bocais para a execuÇço do processo
CO2022001865A2 (es) Administración de cannabinoides no inmunogénicos biorremediadores
BRPI0405436A (pt) Processo para a produção de ácidos carboxìlicos insaturados ou de nitrilas insaturadas
WANG et al. Prospects of obtaining carrageenase from Polar microorganisms
Kocić et al. Potentially effective and safe anti-helicobacter pylori natural products: chemometric study
FR3031682B1 (fr) Procede et installation de production d'un produit poreux en poudre
BR112021020320A2 (pt) Processo para produção contínua de um granulado de substância ativa
BR102014017043B8 (pt) Sistema de tratamento de esgotos domésticos por biodigestão
XIONG Promotion of Ziyuglycoside I on white blood cells by autophagy pathway
BR112021020282A2 (pt) Processo para a produção contínua de um granulado de substância ativa
BR112015022769A2 (pt) extração de nitrogênio de materiais orgânicos por amonificação com populações bacterianas mistas
EP3485952A3 (fr) Procédé écologique d'amélioration de la disponibilité des substances actives issues de matières végétales, utilisation en alimentation animale et composition alimentaire
Sung et al. Identifying the Effects of Jurisdiction-Related Characteristics on the Highway Safety of Vulnerable Users

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200228

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7